Pharmacogenomics : the search for individualized therapies
Author(s)
Bibliographic Information
Pharmacogenomics : the search for individualized therapies
Wiley-VCH, 2002
Available at 18 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical reference and index
Description and Table of Contents
Description
This work represents the first comprehensive publication in the innovative field of pharmacogenomics, a field which is set to revolutionize pharmaceutical research. In addition to renowned editors, the list of contributors is a "who-is-who" in the field. Broad coverage of all aspects of pharmacogenomics with a full presentation of applications to disease conditions is featured. Anyone involved in pharmaceutical research and drug development needs this book to keep up with this new and revolutionary approach
Table of Contents
Preface.List of Contributors.Color Plates.Introduction to Pharmacogenomics: Promises, Opportunities, and Limitations (U. Meyer). The Human Genome (S. Broder, et al.). Turning SNPs into Useful Makers of Drug Response (J. McCarthy). Association Studies in Pharmacogenomics (L. Essioux, et al.). Genomics Application that Facilitate the Understanding of Drug Action and Toxicity (L. Furness). The Role of Pharmacogenetics in Drug Discovery and Therapeutics (K. Lindpaintner). Pharmacogenomics and Drug Design (P. Dean, et al.). The Pharmacogenomics of Human P--Glycoprotein (M. Fromm & M. Eichelbaum). Pharmacogenomics of Drug Transporters (R. Tirona & R. Kim). Pharmacogenomics of Asthma Treatment (L. Palmer, et al.). Endothelial Cells are Targets for Hydroxy Urea: Relevance to the Current Therapeutic Strategy in Sickle Cell Disease (C. Lapoumeroulie, et al.). Pharmacogenomics and Complex Cardiovascular Disease -- Clinical Studies in Candidate Genes (B. Winkelmann, et al.). Pharmacogenomics of Lipid--Lowering Agents (M. Hoffmann, et al.). Pharmacogenomics of Chemotherapeutic Agents in Cancer Treatment (F. Innocenti, et al.). Pharmacogenomics of the Blood--Brain Barrier (J.--M. Scherrmann). Pharmacogenomics and the Treatment of Neurological Disease (D. Goldstein, et al.). Pharmacogenomics of Neurodegenerative Diseases: Examples and Perspectives (P. Hantraye, et al.). Psychiatric Pharmacogenetics: Prediction of Treatment Outcomes in Schizophrenia (M. Masellis, et al.). Pharmacogenomics of Major Depression and Antidepressant Treatment (M.--L. Wong, et al.). Pharmacogenomics of Bipolar Disorder (H. Manji, et al.). Pharmacogenomics of Alcoholism (T. Hurley, et al.). Pharmacogenomics of Tobacco Addiction (E. Johnstone, et al.). Pharmacogenomics of Opioid Systems (T. Reisine). Ethnicity and Pharmacogenomics (H. McLeod & M. Ameyaw). Pharmacogenomics: Ensuring Equity Regarding Drugs Based on Genetic Difference (P. Epps & M. Rothstein). Translation of Vascular Proteomics into Individualized Therapeutics (R. Pasqualini & W. Arap). Glossary of Key Terms in Molecular Genetics of Pharmacogenomics (B. Winkelmann, et al.). Index.
by "Nielsen BookData"